Sharemaestro Newsreel

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Aug. 09, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and certain of its officers. This lawsuit seeks to recover …

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus

Wall Street’s major market averages ended higher on Friday after July's nonfarm payrolls surprised to the downside, showing an unexpected contraction in employment. The blue-chip Dow edged up 0.3%, the benchmark S&P 500 gained 0.62%, and the tech-focused Nasdaq Composite jumped 1.3%. The S&P …

Regeneron Pharmaceuticals (REGN) Keeps Buybacks And Dividend In Focus As Fair Value Stays In Sight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Dividend, earnings and buybacks in focus Regeneron Pharmaceuticals (REGN) has given investors several fresh data points to consider after confirming a quarterly dividend, releasing …

Notícias das Ações da Sarepta Therapeutics Inc (SRPT)

Demonstração de Resultados de Bio-Techne Corp T1CH34

Projeções de Resultados: Sarepta Therapeutics Inc (SRPT) — LPA e Crescimento de Receita

Moderna (MRNA) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, July 31, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Stphane BancelPresident - Stephen HogeChief Financial Officer - James MockChief Development Officer - David Berman TAKEAWAYS Total Revenue -- $145 million, representing 2% growth …

BioNTech (BNTX) Brings In New CEO As Europe Clears Updated COVID 19 Shot

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. BioNTech (NasdaqGS:BNTX) named Dr. Guido Oelkers as incoming CEO, marking a major leadership transition …

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WILMINGTON, Del., August 07, 2026--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it granted restricted stock unit awards (RSUs) representing an aggregate of 21,556 shares of the Company's common stock and stock option awards to purchase an aggregate of 18,172 shares of the Company's …

Is Bio-Techne (TECH) Above Fair Value After A 44% Return?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Bio-Techne stock has delivered a strong 44.2% return over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market …

Notícias das Ações da BioMarin Pharmaceutical Inc (BMRN)

Projeções de Resultados: Moderna Inc (MRNA) — LPA e Crescimento de Receita

As ações da Moderna sobem ligeiramente após a empresa elevar a previsão de receita

A previsão sobre o preço das ações da Moderna para 2026, 2027, 2028–2030 e posteriores

Moderna (M1RN34) decepciona em lucro e receita do 3° tri; veja

BDR Sarepta Therapeutics - S1RP34 - Resultados, Dividendos, Cotação e Indicadores

BDR Bio-Techne - T1CH34 - Resultados, Dividendos, Cotação e Indicadores

BDR Argenx - A1RG34 - Resultados, Dividendos, Cotação e Indicadores

Stock Incyte - Stock INCY - Resultados, Dividendos, Cotação e Indicadores

Stock Moderna - Stock MRNA - Resultados, Dividendos, Cotação e Indicadores

BIOM3 - Biomm - Resultados, Dividendos, Cotação e Indicadores

Análise técnica do Moderna, Inc. (NASDAQ:MRNA)